Hagar Kalinski

This inventor holds 25 USPTO granted patents and 21 published patent applications, plus 5 CIPO patents and 11 EPO patents, primarily in Oligonucleotide Therapeutics. Top assignees: Quark Pharmaceuticals, Inc., Nitto-Denko Corporation, Washington University. Active years: 2009-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hagar Kalinski. Retrieved from https://idiyas.com/inventor/hagar-kalinski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 (Patent Applications = 21)

% Patents Active = 48.0

CIPO Patents = 5 (Patent Applications = 4)

EPO Patents = 11 (Patent Applications = 19)

Average Co-Inventor Count = 5.6

ph-index = 8

Forward Citations = 185(Granted Patents)

Company Filing History:

17 out of 67

Quark Pharmaceuticals, Inc.

patents

8 out of 3,951

Nitto-Denko Corporation

patents

2 out of 1,383

Washington University

patents

where one patent can have more than one assignee

Years Active: 2009-2020

Loading Chart...

Areas of Expertise:

Oligonucleotide

p53

DDIT4

siRNA

Fibrosis

HSP47

Lung Disease

Eye Disorders

RhoA

NRF2

Hypoxia

Drug Carrier

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10781449 - Double-stranded oligonucleotide molecules targeting p53 and methods of use thereof (2020-09-22),

2. 10421962 - Double-stranded oligonucleotide molecules to DDIT4 and methods of use thereof (2019-09-24),

3. 10196637 - Retinoid-lipid drug carrier (2019-02-05),

4. 10195145 - Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier (2019-02-05),

5. 10093923 - Modulation of HSP47 expression (2018-10-09),

6. 9932578 - Double-stranded oligonucleotide molecules to P53 and methods of use thereof (2018-04-03),

7. 9822362 - Compositions and methods for treating lung disease and injury (2017-11-21),

8. 9796979 - Oligonucleotide modulators of the toll-like receptor pathway (2017-10-24),

9. 9701961 - Methods for treating eye disorders (2017-07-11),

10. 9611474 - Double-stranded oligonucleotide molecules to DDIT4 and methods of use thereof (2017-04-04),

11. 9487778 - Oligonucleotide modulators of the toll-like receptor pathway (2016-11-08),

12. 9456984 - Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier (2016-10-04),

13. 9446062 - Methods of treating ischemia-reperfusion injury with siRNAs (2016-09-20),

14. 9206424 - Modulation of HSP47 expression (2015-12-08),

15. 9205100 - Compositions and methods for treating lung disease and injury (2015-12-08),

Title: Inventor Hagar Kalinski - Revolutionizing Technology in Rishon-Le-Zion

Introduction: Hagar Kalinski, a pioneering inventor based in Rishon-Le-Zion, Israel, is renowned for her groundbreaking contributions to the field of technology. As a woman in a predominantly male-dominated industry, she has shattered barriers and continues to inspire aspiring inventors worldwide.

Latest Patents: Hagar Kalinski's latest patents include innovative solutions in renewable energy storage systems and advanced artificial intelligence algorithms for autonomous vehicles. Her forward-thinking approach to technology has positioned her as a leading figure in the industry.

Career Highlights: With a career spanning over two decades, Hagar Kalinski has a proven track record of developing cutting-edge technologies that have redefined various sectors. From her early days as a research assistant to founding her own tech startup, she has consistently pushed the boundaries of innovation.

Collaborations: Throughout her career, Hagar Kalinski has collaborated with top research institutions, leading tech companies, and visionary inventors from around the globe. These collaborations have not only enriched her work but have also led to the development of groundbreaking technologies that have had a lasting impact on society.

Conclusion: In conclusion, Hagar Kalinski's passion for innovation, coupled with her relentless drive to create a better future through technology, sets her apart as a true visionary in the world of inventions. Her journey serves as a testament to the power of perseverance, creativity, and dedication in shaping the world we live in today

Profile summary based on public USPTO records.